Ten-Year Breast Cancer Survival Improved In Past 60 Years, MD Anderson Study Finds
Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival
Racial Disparities Remain In Breast Cancer Care
DCIS With Higher Density May Increase Risk For Disease
Choice Of Reconstruction Can Depend On Who Consults
Only 20% of Doctors Advise CRC According To Guidelines
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- In The Headlines: HHS shakeup threatens a legacy of medical breakthroughs
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed - Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure